Stockreport

IceCure gets favorable FDA AdCom vote for ProSense System [Seeking Alpha]

IceCure Medical Ltd. - Ordinary Shares  (ICCM) 
PDF for its ProSense System for the destruction of early-stage breast cancer tumors using cryoablation technology. The committee voted 9 to 5 that the benefits of the syst [Read more]